RealMind Biotech

ABOUT US

Headquartered in Nanjing, China, and founded in June 2015, RealMind Biotech is a high-tech enterprise dedicated to advancing global healthcare through innovative in vitro diagnostic solutions. The company specializes in the development, manufacturing, and sale of advanced, fully automated, compact chemiluminescence immunoassay (CLIA) systems and reagents, driven by the mission "For Better Diagnosis." RealMind Biotech has achieved significant market penetration, serving top-tier hospitals across 25 provinces in China and maintaining partnerships in over 20 countries worldwide, backed by over 100 CE certifications and 75 NMPA certificates as of July 2025. Supported by renowned investors like Sequoia Capital and strategic partners including Roche Diagnostics (China), the company delivers precise and efficient diagnostic tools to improve clinical outcomes globally.